Xueli Bai

机构：Shanxi Medical University, Zhejiang Cancer Hospital, Fourth Affiliated Hospital of China Medical University, Blood Center of Zhejiang Province, Shanghai Clinical Research Center, Shanxi Academy of Medical Sciences, Tongji Hospital, Pancreas Centre (Canada), First Affiliated Hospital Zhejiang University, Huazhong University of Science and Technology, Zhejiang University, China Medical University

发表论文 17 篇 · 总被引 164 次 · h-index 5

代表论文

• Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma (2025 · Journal of Clinical Investigation · 被引 97)
• Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial (2025 · Hepatology · 被引 28)
• Emerging immunotherapy and tumor microenvironment for advanced sarcoma: a comprehensive review (2025 · Frontiers in Immunology · 被引 9)
• Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma (2024 · Cell Reports Medicine · 被引 8)
• Knowledge, attitudes and practices regarding pulmonary rehabilitation among patients with chronic respiratory diseases: a cross-sectional questionnaire-based study in a tertiary hospital in China (2025 · BMJ Open · 被引 5)
• Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma (2024 · BMC Medicine · 被引 4)